After this process, five leads identified during the Discovery study (CDKN1B, NPM1, VIM, HSPD1 and HNRNPL) and one lead from our previous work (GBU4-5) no longer showed ability to distinguish HCC from NCCLD samples. The gene discussed is HNRNPL; the disease is hepatocellular carcinoma.